Related Experiment Video
Updated: Jul 3, 2026

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
Fungal infections after lung transplantation
1Pulmonary Transplant Unit, Hospital Universitario La Fe, 46009 Valencia, Spain. sole_amp@gva.es
Abstract:
Lung transplantation (LT) is now considered to be the standard therapeutic intervention in some patients with end-stage pulmonary disease. Infectious complications after LT are relatively common due to the aggressive immunosuppression used in these receptors and local host factors derived from this type of transplant. The incidence of fungal infections after LT ranges up to 30%. However, the incidence of invasive mycoses has declined over the past decade. These mycoses are associated with high overall mortality rates despite increase of the antifungal armamentarium in the last years. Candida and Aspergillus spp produce most of these infections, but unusual moulds such as Scedosporium spp are increasingly recognized as opportunistic pathogens in LT. This review highlights the changing spectrum of invasive fungal infections, risk factors, antifungal prophylaxis, diagnosis, and treatment after LT.
Insights
Lung transplantation (LT) patients face common fungal infections, with an incidence up to 30%. While invasive mycoses have declined, they remain a significant cause of mortality, necessitating effective antifungal strategies.
Area of Science:
- Pulmonology
- Infectious Diseases
- Transplant Medicine
Background:
- Lung transplantation (LT) is a vital treatment for end-stage pulmonary disease.
- Infectious complications, particularly fungal infections, are prevalent post-LT due to immunosuppression.
- Fungal infections occur in up to 30% of lung transplant recipients.
Purpose of the Study:
- To review the evolving landscape of invasive fungal infections following lung transplantation.
- To identify key risk factors, diagnostic approaches, and therapeutic strategies for fungal infections in LT recipients.
- To highlight the changing spectrum of fungal pathogens, including emerging molds.
Main Methods:
- Literature review focusing on invasive fungal infections in lung transplant recipients.
- Analysis of incidence, causative agents, and mortality rates of fungal infections.
- Examination of current practices in antifungal prophylaxis, diagnosis, and treatment.
Main Results:
- The incidence of invasive fungal infections post-LT ranges up to 30%, though it has declined recently.
- Candida and Aspergillus species are common, but unusual molds like Scedosporium are increasingly recognized.
- Despite advances in antifungals, invasive mycoses are associated with high mortality rates.
Conclusions:
- Fungal infections remain a critical challenge in lung transplant recipients.
- Early diagnosis and appropriate antifungal treatment are crucial for improving outcomes.
- Ongoing surveillance and research are needed to manage the changing spectrum of fungal pathogens.
Related Concept Videos
Cryptococcal Meningitis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Kidney Transplant III: Nursing Management
Pneumothorax-II
Clinical Manifestations:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

